March 22nd 2023
Patients with metastatic or recurrent locally advanced Merkel cell carcinoma can now receive treatment with retifanlimab-dlwr following its accelerated approval by the FDA.
ASCO 2015: Developmental Therapeutics Immunotherapy Poster DiscussionJune 22nd 2015
Not surprisingly, this was a very popular topic. I’m not sure why the ASCO planners didn’t anticipate this, because I had to wait a few minutes outside the door to even get in. At one point, it was standing room only!
Vitamin B3 Supplement Reduced Occurrences of Basal and Squamous Cell CarcinomasJune 6th 2015
In this video, Dr. Martin discusses the phase III ONTRAC study, which found that the use of nicotinamide, a form of vitamin B3, reduced the incidence of non-melanoma skin cancers by 23% among a group of high-risk patients.
Examining BRAF-Inhibitor Resistance Offers Few Clues in Melanoma TreatmentMay 31st 2015
Due to the genetic heterogeneity observed in tumors of melanoma patients who developed resistance to BRAF inhibitors, assessing mechanisms of resistance has minimal potential to inform further treatment decisions.